Literature DB >> 9484843

Cisplatin induces a persistent activation of JNK that is related to cell death.

I Sánchez-Perez1, J R Murguía, R Perona.   

Abstract

Genotoxic stress triggers signalling pathways that either mediate cell killing or protection of affected cells. While induction of p53 is observed for most of the genotoxins, activation of MAPK/SAPK cascades is not a general response. The role of MAPK/SAPK activation on cell fate, seems to be dependent, in some systems, on the balanced response among both cascades. We have here examined the effect of cis and trans-DDP on the activation of ERK and JNK activities. While no significant induction of ERK was observed with the compounds, both of them are able to strongly activate JNK. Trans-DDP response is rapid and transient while the cis-DDP one is slow and persistent. In contrast with the observed nuclear translocation of JNK in response to U.V. light, none of the platinum compounds induces translocation, on the contrary, activation of JNK occurs in both the nuclear and cytoplasmic compartments. Inhibition of tyrosine phosphatases by orthovanadate pretreatment prolongs the time of JNK induction in response to both platinum compounds. The positive modulation of JNK activation correlates with an increase in toxicity that, for cis-DDP corresponds to a tenfold decrease in the IC50. A strong increase in MKP-1 levels was observed only in response to trans-DDP suggesting the involvement of this activity in the downregulation of JNK activity in response to this compound. Altogether the results suggest that the prolonged activation of JNK in response to cis-DDP contributes to cell death induction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9484843     DOI: 10.1038/sj.onc.1201578

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  71 in total

1.  A nuclear tyrosine phosphorylation circuit: c-Jun as an activator and substrate of c-Abl and JNK.

Authors:  D Barilá; R Mangano; S Gonfloni; J Kretzschmar; M Moro; D Bohmann; G Superti-Furga
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

2.  Involvement of p38 in apoptosis-associated membrane blebbing and nuclear condensation.

Authors:  R G Deschesnes; J Huot; K Valerie; J Landry
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

3.  Hinesol, a compound isolated from the essential oils of Atractylodes lancea rhizome, inhibits cell growth and induces apoptosis in human leukemia HL-60 cells.

Authors:  Yutaka Masuda; Takayuki Kadokura; Maki Ishii; Kimihiko Takada; Junichi Kitajima
Journal:  J Nat Med       Date:  2015-04-02       Impact factor: 2.343

4.  Proteomics and pathway analysis identifies JNK signaling as critical for high linear energy transfer radiation-induced apoptosis in non-small lung cancer cells.

Authors:  Sara Ståhl; Eva Fung; Christopher Adams; Johan Lengqvist; Birgitta Mörk; Bo Stenerlöw; Rolf Lewensohn; Janne Lehtiö; Roman Zubarev; Kristina Viktorsson
Journal:  Mol Cell Proteomics       Date:  2009-01-23       Impact factor: 5.911

5.  Apoptosis of bone marrow mesenchymal stromal/stem cells via the MAPK and endoplasmic reticulum stress signaling pathways.

Authors:  Tielong Chen; Houyong Zhu; Yu Wang; Pengjie Zhao; Jingyu Chen; Jing Sun; Xiudong Zhang; Guangli Zhu
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

6.  Activation of c-Jun NH2-terminal kinase is required for gemcitabine's cytotoxic effect in human lung cancer H1299 cells.

Authors:  Fuminori Teraishi; Lidong Zhang; Wei Guo; Fengqin Dong; John J Davis; Anning Lin; Bingliang Fang
Journal:  FEBS Lett       Date:  2005-11-14       Impact factor: 4.124

7.  Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer.

Authors:  F Bataille; P Rümmele; W Dietmaier; D Gaag; F Klebl; A Reichle; P Wild; F Hofstädter; A Hartmann
Journal:  Mol Pathol       Date:  2003-10

8.  Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin.

Authors:  Christina Peklak-Scott; Pamela K Smitherman; Alan J Townsend; Charles S Morrow
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

9.  FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells.

Authors:  Silvia Fernández de Mattos; Priam Villalonga; Jon Clardy; Eric W-F Lam
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

10.  Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y.

Authors:  Elisabetta Donzelli; Maria Carfì; Mariarosaria Miloso; Alberto Strada; Stefania Galbiati; Martine Bayssas; Genevieve Griffon-Etienne; Guido Cavaletti; Maria Grazia Petruccioli; Giovanni Tredici
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.